Catherine Ramsey
Stock Analyst at Baird
(3.65)
# 901
Out of 4,876 analysts
49
Total ratings
50%
Success rate
8.31%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Catherine Ramsey
Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
WAT Waters | Maintains: Outperform | $355 → $374 | $352.41 | +6.13% | 10 | May 7, 2025 | |
TWST Twist Bioscience | Maintains: Outperform | $54 → $44 | $35.93 | +22.46% | 7 | May 6, 2025 | |
RVTY Revvity | Maintains: Outperform | $127 → $125 | $97.82 | +27.79% | 5 | Apr 29, 2025 | |
ILMN Illumina | Maintains: Neutral | $127 → $90 | $94.79 | -5.05% | 5 | Mar 5, 2025 | |
NTRA Natera | Maintains: Outperform | $183 → $188 | $167.96 | +11.93% | 6 | Feb 28, 2025 | |
CSTL Castle Biosciences | Maintains: Outperform | $36 → $37 | $20.39 | +81.51% | 8 | Feb 28, 2025 | |
TMO Thermo Fisher Scientific | Maintains: Outperform | $695 → $665 | $408.28 | +62.88% | 2 | Nov 1, 2022 | |
A Agilent Technologies | Maintains: Outperform | $155 → $160 | $119.17 | +34.26% | 5 | Aug 17, 2022 | |
EXAS Exact Sciences | Maintains: Outperform | $90 → $75 | $53.65 | +39.79% | 1 | Aug 3, 2022 |
Waters
May 7, 2025
Maintains: Outperform
Price Target: $355 → $374
Current: $352.41
Upside: +6.13%
Twist Bioscience
May 6, 2025
Maintains: Outperform
Price Target: $54 → $44
Current: $35.93
Upside: +22.46%
Revvity
Apr 29, 2025
Maintains: Outperform
Price Target: $127 → $125
Current: $97.82
Upside: +27.79%
Illumina
Mar 5, 2025
Maintains: Neutral
Price Target: $127 → $90
Current: $94.79
Upside: -5.05%
Natera
Feb 28, 2025
Maintains: Outperform
Price Target: $183 → $188
Current: $167.96
Upside: +11.93%
Castle Biosciences
Feb 28, 2025
Maintains: Outperform
Price Target: $36 → $37
Current: $20.39
Upside: +81.51%
Thermo Fisher Scientific
Nov 1, 2022
Maintains: Outperform
Price Target: $695 → $665
Current: $408.28
Upside: +62.88%
Agilent Technologies
Aug 17, 2022
Maintains: Outperform
Price Target: $155 → $160
Current: $119.17
Upside: +34.26%
Exact Sciences
Aug 3, 2022
Maintains: Outperform
Price Target: $90 → $75
Current: $53.65
Upside: +39.79%